Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Spironolactone plus finasteride reduces hirsutism more effectively.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.